NCT06174779View on ClinicalTrials.gov

A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

January 3, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
Obesity
Interventions
DRUG

HM11260C

Test drug

DRUG

Placebo

Placebo drug

Trial Locations (1)

Unknown

Kangbuk samsung hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY